View in EDS

Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b

Saved in:
Bibliographic Details
Title: Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b
Authors: Brandberg, Y.1 yvonne.brandberg@ki.se, Aamdal, S.2, Bastholt, L.3, Hernberg, M.4, Stierner, U.5, von der Maase, H.6,7, Hansson, J.1
Source: European Journal of Cancer. Sep2012, Vol. 48 Issue 13, p2012-2019. 8p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 79111186
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Brandberg%2C+Y%2E%22">Brandberg, Y.</searchLink><relatesTo>1</relatesTo><i> yvonne.brandberg@ki.se</i><br /><searchLink fieldCode="AR" term="%22Aamdal%2C+S%2E%22">Aamdal, S.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Bastholt%2C+L%2E%22">Bastholt, L.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Hernberg%2C+M%2E%22">Hernberg, M.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Stierner%2C+U%2E%22">Stierner, U.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22von+der+Maase%2C+H%2E%22">von der Maase, H.</searchLink><relatesTo>6,7</relatesTo><br /><searchLink fieldCode="AR" term="%22Hansson%2C+J%2E%22">Hansson, J.</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Cancer%22">European Journal of Cancer</searchLink>. Sep2012, Vol. 48 Issue 13, p2012-2019. 8p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=79111186
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2011.11.019
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 2012
    Titles:
      – TitleFull: Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Brandberg, Y.
      – PersonEntity:
          Name:
            NameFull: Aamdal, S.
      – PersonEntity:
          Name:
            NameFull: Bastholt, L.
      – PersonEntity:
          Name:
            NameFull: Hernberg, M.
      – PersonEntity:
          Name:
            NameFull: Stierner, U.
      – PersonEntity:
          Name:
            NameFull: von der Maase, H.
      – PersonEntity:
          Name:
            NameFull: Hansson, J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2012
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-print
              Value: 09598049
          Numbering:
            – Type: volume
              Value: 48
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: European Journal of Cancer
              Type: main
ResultId 1